Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MOBI

Mobia Medical Inc

11.70

Aug 04 • 9:45 AM ET +0.35 (3.08%)

Healthcare Medical Devices USA Small NASD

Peers: OFIX ATEC INMD BFLY LMAT LIVN MMSI GMED VCYT BLCO

| Held by: VTI VXF SCHA VTWO MSSM VTWG VTWV VTHR

Scroll to Statements

Index	-
Market Cap	389.02M
Enterprise Value	562.27M
Income	-
Sales	-
Book/sh	-5.05
Cash/sh	1.68
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	167
IPO	May 08, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	6.98
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	5.25
Current Ratio	5.76
Debt/Eq	4.09
LT Debt/Eq	4.06
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-2.17
EPS next Q	-0.71
EPS this Y	95.07%
EPS next Y	19.63%
EPS next 5Y	66.03%
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	Aug 11 BMO
EPS/Sales Surpr.	-2.77% -0.09%

Insider Own	50.66%
Insider Trans	8.18%
Inst Own	1.76%
Inst Trans	6.26%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	0.57%
SMA50	-7.02%
SMA200	-6.56%
Trades

Shs Outstand	33.25M
Shs Float	16.40M
Short Float	2.58%
Short Ratio	2.20
Short Interest	0.42M
52W High	15.29 -23.48%
52W Low	10.19 14.87%
Volatility	7.79% 8.02%
ATR (14)	0.88
RSI (14)	48.90
Beta	-
Rel Volume	0.01
Avg Volume	192.17K
Volume	94

Perf Week	9.14%
Perf Month	-11.70%
Perf Quarter	-
Perf Half Y	-
Perf YTD	-16.43%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	17.25
Prev Close	11.35
Price	11.70
Change	3.08%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-02-26	Initiated	JP Morgan	Overweight	$15
Jun-02-26	Initiated	Goldman	Buy	$31
Jun-02-26	Initiated	BTIG Research	Buy	$19
Jun-02-26	Initiated	BofA Securities	Buy	$16

Aug-03-26 04:05PM	Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directors (GlobeNewswire)
Jul-21-26 04:05PM	Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026 (GlobeNewswire) -7.76%
Jul-15-26 04:05PM	Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors (GlobeNewswire)
Jul-14-26 04:18PM	Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim Paired VNS Therapy (GlobeNewswire)
Jul-02-26 04:35PM	Mobia Medical Announces Vivistim Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule (GlobeNewswire)
03:28PM	Loading…
Jun-02-26 03:28PM	Mobia Medical poised for commercial expansion, BofA says in initial coverage (Proactive)

Mobia Medical, Inc. operates as a commercial-stage medical device company. It engages in developing solutions for stroke recovery survivors with motor impairments. The company was founded by Lawrence James Cauller, Navzer Engineer, Thomas Jordan Curnes II, and William Michael Rosellini on March 5, 2007 and is headquartered in Austin, TX.

CEOMr. Richard John Foust

M.B.A.Mr. Thomas Jordan Curnes II

Chief Financial OfficerMr. Nelson Bunker Curnes

Chief Operating OfficerMr. Prashant B. Rawat

Chief Commercial OfficerMr. Douglas T. Ellison

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rawat Prashant B.	Chief Operating Officer	Jun 10 '26	Option Exercise	3.38	15,000	50,700	15,000	Jun 12 04:20 PM
Curnes Nelson Bunker	Chief Financial Officer	Jun 09 '26	Buy	12.79	5,000	63,969	366,997	Jun 11 07:10 PM
Osage University GP III, LLC	10% Owner	May 11 '26	Buy	15.00	533,333	7,999,995	2,006,716	May 12 04:17 PM
Tansey Casey M	Director	May 11 '26	Buy	15.00	66,666	999,990	233,332	May 11 09:58 PM
HARRINGTON WILLIAM T	Director	May 11 '26	Buy	15.00	533,333	7,999,995	2,006,716	May 11 09:36 PM
Lucchese Cynthia L	Director	May 11 '26	Buy	15.00	125,000	1,875,000	125,000	May 11 09:36 PM
Leavitt Chase C.	See Remarks	May 11 '26	Buy	15.00	3,000	45,000	3,000	May 11 09:36 PM
Mead Dana G Jr.	Director	May 11 '26	Buy	15.00	7,000	105,000	7,000	May 11 09:36 PM

MOBI

Mobia Medical Inc

Upgrade your Finviz experience